首页> 外文期刊>therapeutic drug monitoring >Comparison of EMIT Versus Bioassay to Evaluate Inactivation of Tobramycin by Piperacillin
【24h】

Comparison of EMIT Versus Bioassay to Evaluate Inactivation of Tobramycin by Piperacillin

机译:Comparison of EMIT Versus Bioassay to Evaluate Inactivation of Tobramycin by Piperacillin

获取原文
           

摘要

SummaryWe evaluated and compared the sensitivity of enzyme multiplied immunoassay (EMIT) and bioassay techniques in detecting the degree of inactivation of tobramycin by piperacillin in serum specimens. Specimens were prepared to contain initial tobramycin concentrations of 10 (mu;g/ml and piperacillin concentrations of 62.5, 125.0, 250.0, and 500 mu;g/ml. The samples were stored at room temperature (25deg;C), in the refrigerator (4deg;C), and in the freezer (mdash; 10deg;C) for up to 7 days. Tobramycin concentrations were determined by the two assay methods at the conclusion of 1, 3, and 6 h and 1,3,5, and 7 days of storage. The percentage of tobramycin activity as measured by EMIT and bioassay differed throughout the study period. Statistical analysis revealed that the assay method was the only significant variable to contribute to the variability observed in the differences of tobramycin concentration. Our results suggest that the bioassay technique is more sensitive than the EMIT assay for detecting the degree of inactivation of tobramycin by piperacillin. The EMIT assay overestimates tobramycin concentrations, which may be due to measurement of active and inactive tobramycin.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号